Boys, Mark Laurence,Delisle, Robert Kirk,Hicken, Erik James,Kennedy, April L.,Mareska, David A.,Marmsater, Fredrik P.,Munson, Mark C.,Newhouse, Brad,Rast, Bryson,Rizzi, James P.,Rodriguez, Martha E.,T
申请号：
AU2018201903
公开号：
AU2018201903A1
申请日:
2018.03.16
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018201903A120180412.pdf#####ABSTRACT [007801 Compounds of Formula I: R N R2 NH NHN O N R 3 N R1 R6 and pharmaceutically acceptable salts thereof in which R', R2, R, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.
